Why is Nidan Laborator. falling/rising?

As of 29-Jul, Nidan Laboratories & Healthcare Ltd is experiencing a decline in its stock price, currently at 19.05, which reflects a decrease of 0.9 or 4.51%. The stock has underperformed its sector today by 5.22%, and it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has seen a return of -5.22%, and its performance over the last month shows a significant decline of -12.41%. Additionally, the company has not declared results in the last six months, contributing to weak long-term fundamental strength. The stock has generated a return of -45.34% over the past year, while profits have fallen by 40%, indicating deteriorating financial health.
In the broader market context, the Sensex has only declined by 0.96% over the past week, highlighting that Nidan Laboratories is underperforming relative to the benchmark. The company's weak ability to service its debt, as evidenced by a poor EBIT to Interest ratio of 1.75, further exacerbates investor concerns. Despite having an attractive valuation with a return on capital employed of 3.5, the overall negative sentiment surrounding the stock, driven by its flat results and below-par performance in both the long and near term, suggests that investors are cautious, leading to the current downward trend in its stock price.